Watertown Regional Medical Center is now offering Regeneron-COV monoclonal antibody treatment as an outpatient service in our ambulatory care department.
What is it used for?
The monoclonal antibody infusion for COVID-19 that we currently offer is Regeneron-COV. Regeneron-COV is authorized for the treatment of mild to moderate confirmed COVID-19 in outpatients 12 years and older whose symptoms onset occurred within the past 10 days and are at high risk of progression to severe COVID-19 and/or hospitalization. It is also authorized for people who have had significant exposure to a COVID-19 positive patient.
What is it and what does it do?
Regeneron-COV consists of the monoclonal antibodies casirivimab and imdevimab, administered together. Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful viruses. This therapy is designed to help block the COVID-19 virus and prevent the virus from further infecting healthy cells.
Can I receive Regeneron-COV if I've been vaccinated?
Yes. Vaccination status does not disqualify any individual from receiving the Regeneron-COV if they meet the other conditions and criteria.
Do I qualify?
Watertown Regional Medical Center is able to provide monoclonal antibody infusion therapy for treatment or prophylaxis if the following conditions and criteria are met.
Patients with mild to moderate COVID-19 symptoms in adult and pediatric patients (12 years of age and older and weighing at least 88 lbs.) with positive results of direct COVID-19 viral testing, and who are at a high risk for progression to severe COVID-19.
Treatment must be given as soon as possible after a positive COVID-19 test and within 10 days of symptom onset.
- High-risk conditions include:
- Older than 65 years of age
- Obesity or overweight
- Chronic kidney disease
- Immunosuppressive disease or immunosuppressive treatment
- Cardiovascular disease including congenital heart disease
- Chronic lung diseases
- Sickle cell disease
- Neurodevelopmental disorders
- Medical related technological dependence, e.g., tracheostomy, gastrostomy, or positive pressure ventilation not related to covid-19
Adult and pediatric individuals (12yrs of age and older weighing at least 88 pounds) who have had significant exposure to a COVID-19 positive patient and who are at high risk for progression to severe COVID-19, including hospitalization or death.
- Individuals who are not fully vaccinated or who are not expected to mount an adequate immune response to complete COVID-19 vaccination and
- Have been in close contact with an individual infected with COVID-19
- Are at high risk of exposure to an individual infected with COVID-19
- Individuals who repeat dosing is determined to be appropriate for ongoing exposure to COVID-19 for longer than 4 weeks and are not expected to mount an adequate immune response to complete COVID-19 vaccination
What are some reasons I may not qualify?
- Hospitalized due to COVID-19
- Require oxygen therapy due to COVID-19 or increase in baseline oxygen flow rate due to COVID-19
- It has been greater than 10 days since COVID-19 symptoms started
- Weigh less than 88 pounds
- Are under 12 years of age